SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?


To: Sir Auric Goldfinger who wrote (12125)9/15/2003 5:59:14 PM
From: StockDung  Respond to of 19428
 
Dynacq International, Inc. Analyst: Howard Halpern
Taglich Rating: Speculative Buy
Price Target: $24.45
Time Horizon: 12 Months
Rating Established: July 31, 2003
Price When Established: $19.63


What's New
Updated Research Report (Dated July 31, 2003)

Company Description
Dynacq International Inc. (DYII) serves the local community in Pasadena within Harris County, Texas as a community provider of medical care services. Their services include an outpatient surgical and 41-bed acute care hospital facility, a medical office complex, management of group physician practices, home infusion healthcare services and supplies to patients in their homes. As of May 31, 2000 they had approximately, 125 employees.



To: Sir Auric Goldfinger who wrote (12125)9/15/2003 6:03:01 PM
From: RockyBalboa  Read Replies (1) | Respond to of 19428
 
Excellent, Sir! Known name, dubious coverage,...

The community is leaning mightily against TSMC, stock drops..., looks like a dog.



To: Sir Auric Goldfinger who wrote (12125)9/15/2003 6:06:29 PM
From: StockDung  Respond to of 19428
 
Taglich Brothers – DISCLAIMER lol"Companies, which are published, pay a monthly fee for the creation and dissemination of research reports. Details of compensation from such companies are available upon request."

AVAILABLE UPON REQUEST? LOL THE LAW SAYS YOU MUST DISCLOSE AND UPON REQUEST IS NOT PROPER DISCLOSURE. YOU MUST DISCLOSE EXACT COMPENSATION ON WEB SITE AND WHO PAID YOU. DO NOT PASS GO. DO NOT COLLECT $200 WITHOUT DISCLOSING

UNLESS YOU ARE THE NASDAQ AND CONTINUE TO LOOK THE OTHER WAY!!

Taglich Brothers – DISCLAIMER
Taglich Brothers, Inc. is a broker/dealer, which publishes research reports with respect to some of the securities that it follows. The information contained herein is based upon sources which we believe to be reliable, but is in no way warranted by us as to accuracy or completeness. The information contained herein is subject to change without notice, and we assume no responsibility to update the information in our reports.

We, our affiliates, and any officer, director or stockholder or any member of their families may have a position in and may from time to time purchase or sell any securities discussed in our reports. An employee, analyst, officer, or a director of the firm, or its affiliates, may serve as a director for companies mentioned in our reports. There may be instances when fundamental, technical, and quantitative opinions may not be in concert. This firm (or one of its affiliates) may from time to time perform investment banking or other services for, or solicit investment banking or other business from, any company mentioned on this web site. Companies, which are published, pay a monthly fee for the creation and dissemination of research reports. Details of compensation from such companies are available upon request.

The information on this site is not intended to provide tax, legal or investment advice. The information does not constitute a solicitation of any order to buy or sell any securities. The information provided herein may be displayed and printed for your personal, noncommercial use only. You may not reproduce, retransmit, distribute, disseminate, sell, publish, broadcast or circulate the information to anyone, without the express written consent of Taglich Brothers, Inc.

Taglich Brothers – LINKS DISCLAIMER
Links are solely intended for convenience and are not intended to be advertisement whatsoever. Linked sites are not under the control of Taglich Brothers and Taglich Brothers is not responsible for the content of any linked site or any link contained in any linked site. Taglich Brothers does not endorse companies, or their products or services, to which it links. If you decide to access any of the third party sites linked to this site, you do this entirely at your own risk.



To: Sir Auric Goldfinger who wrote (12125)9/16/2003 8:48:09 AM
From: RockyBalboa  Read Replies (6) | Respond to of 19428
 
DYII,, dog, responds to Barrons, stock up a bit.

Press Release Source: Dynacq International Inc.

Dynacq Comments on Barron's Article
Tuesday September 16, 7:55 am ET

HOUSTON--(BUSINESS WIRE)--Sept. 16, 2003--Dynacq International Inc. (NASDAQ/NM:DYII - News) commented today on a Barron's article which analyzed Dynacq's outstanding growth and profitability and provided some of the reasons why the Company is more profitable than most hospital holding companies. After acknowledging that both Forbes and Fortune have recognized Dynacq as one of the outstanding growth companies in America, Barron's writer Rhonda Brammer raised questions whether the Company might face a more difficult environment in the future because of a previous lawsuit with a Texas workers compensation insurance carrier, the possibility of some as yet unannounced regulations from the Texas Workers Compensation Commission and a regulatory proceeding involving a surgeon who had staff privileges (now suspended) at one of the Company's subsidiary hospitals. Dynacq is a holding company which does not operate any hospitals. Any references to hospitals or to cases refer to hospitals owned and operated by Dynacq's subsidiaries and affiliates.
ADVERTISEMENT


The Company believes that the Barron's article provided a slanted and mistaken account of Dynacq's current and future business and dredged up some old news regarding reimbursement disputes with one of the Texas insurers and a regulatory proceeding involving a surgeon who used to have staff privileges at a subsidiary hospital. The Company expects that the article will be welcomed by the short sellers who have been holding short positions of almost 1,500,000 shares of Dynacq stock, probably at a large loss. James N. Baxter, Executive Vice President, said, "The short sellers must be heaving a sigh of relief to have some negative 'news' to permit some covering of positions before the Company reports its results for the fiscal year ended August 31, 2003."

To set the record straight, the following are some of the reasons for Dynacq's remarkable growth and profitability:

Dynacq's business is diversifying away from workers comp
cases. In the last quarter more than 50% of Dynacq's inpatient

surgeries came from weight reduction or bariatric surgery and

related procedures--not workers comp cases. Dynacq's

successful newer subsidiary hospital in Baton Rouge handles

only a single digit percent of workers comp cases. Once

Dynacq's new Dallas hospital begins handling inpatient

surgical cases, expected late this year, the proportion of

Dynacq's workers comp cases is expected to decline further.

The New York Times recently reported that the surging demand

for obesity surgery is creating great demand for the

relatively few hospitals, like Dynacq's subsidiary hospitals

in Pasadena and Baton Rouge, which are equipped to handle this

surgery. We plan for the Dallas hospital to be similarly

configured.

Dynacq subsidiary hospitals focus on pre-certified
out-of-network complex surgical procedures utilizing minimally

invasive high tech surgical devices. Based on the Case Mix

Index of the Centers for Medicare and Medicaid Services,

designed to measure the relative difficulty of medical care

provided in hospitals to support appropriate reimbursements to

the hospitals, the average surgery at Dynacq's Pasadena

subsidiary Vista Medical Center is more than twice the

difficulty of the average surgery in U.S. hospitals overall.

Such surgical procedures understandably are entitled to larger

fees than simpler surgeries. The precertified nature of these

surgeries explains in part why Dynacq expects insurers to pay

Dynacq subsidiary hospitals the amounts which are due in

accordance with existing regulations.

The former litigation with Texas Mutual is a normal part of
Dynacq's business strategy of providing first class medical

facilities for complex surgeries and refusing to accept

payments from insurers which are less than the amounts

scheduled by the Texas Workers Compensation Commission. Texas

Mutual is only one of the workers comp insurance payers in

Texas and it cannot dictate what it is required to reimburse.

Whatever Texas Mutual may assert, only the Texas Workers

Compensation Commission can ultimately determine the

reimbursements. In any event, all of the underpayments by

Texas Mutual which were detailed in the Barron's article have

long since been fully accounted for and will have no adverse

effect on Dynacq's financials. In addition, the hospitals

involved are still pursuing certain of these claims in

administrative appeals.

Dynacq's subsidiary hospitals' use of minimally invasive
techniques and instruments permits patients to return to their

families sooner than traditional surgical techniques would.

Thus the average hospital stay at Dynacq subsidiary hospitals

is about three days. This means that a large number of

inpatient procedures per bed can be accomplished. Because the

hospitals do not keep unnecessary beds, the revenue per bed is

far greater than the rural general hospitals and far larger

HCA hospitals mentioned in the Barron's article.

Dynacq's relatively small size and the newness of its
hospitals permit them to be flexible and efficient in serving

the needs of their patients and doctors practicing in the

hospitals. For example, the hospitals' block scheduling of two

operating rooms for each high volume surgeon provides the

patient and the surgeon the benefit of reliable scheduling and

permits efficient use of the hospital facilities, also

increasing the revenue to the hospital, compared to larger

more inflexible bureaucratic hospitals.

Dynacq through its subsidiaries owns or leases 100% of the
land and buildings and equipment at the hospitals. Physicians

own 8.5% of the operating partnership at Vista Medical Center

in Pasadena, Texas. This is a substantially lower percentage

of physician ownership than that which prevails at a number of

other companies in the industry, and the Company does not

believe that it adversely affects the Company's business.

With the build up of Baton Rouge, the expected operations of
Dallas coming soon and other potential locations being

actively considered, the percentage contribution of Vista

Medical Center Pasadena is expected to decline over time as

anticipated operations from Baton Rouge and Dallas and other

locations are added. The Company is enthusiastic in

contemplating a bright future, especially with the addition of

both Baton Rouge and Dallas.

Any changes in the regulatory system and reimbursement system
of the Texas Workers Compensation Commission will receive the

Company's prompt attention, and, as in the past, management

will make decisions, in compliance with applicable laws and

regulations, which it deems in the best interests of patients

and shareholders. However, an undefined possible new

regulation which has not even been proposed cannot be

addressed by any participant in the healthcare industry,

including Dynacq.

The temporary suspension of the medical license of a
nonemployee physician practicing at any Dynacq hospital is of

course a concern, and Vista Medical Center promptly suspended

Dr.Scheffey's hospital privileges, in accordance with the

hospital's policies. But this concern does not affect Dynacq's

overall business, which is far greater than the status of a

particular doctor's license at a particular subsidiary

hospital.

As previously announced, the U.S. District Court for the
Southern District of Texas has dismissed with prejudice the

class action against Dynacq International Inc. and certain of

its officers which was brought in early 2002 following an

article by Herb Greenberg of The Street.com, which was quoted

in the lawsuit.

Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Although the Company believes its expectations are based on reasonable assumptions within the bounds of its knowledge of its business and operations, there can be no assurance that actual results will not differ materially from its expectations. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. More detailed information about factors that may cause actual results to materially differ is contained in the Company's filings with the Securities and Exchange Commission. The words "looking forward," "believe," "expect," "likely," "contemplating," "anticipating," "bright future" and "near future" and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date that such statements were made. The Company undertakes no obligation to update any forward-looking statements contained in this press release.